AGENDA Information of Event Schedule
Focusing on the design and manufacture of medical devices alongside factors affecting that industry (e.g., regulatory, M&A, quality, legislative), coupled with a keen awareness of challenges associated with the space, the MPO Summit presents a comprehensive agenda that targets many of today's most important issues impacting stakeholders.
8:45-9:00 a.m.
Welcome to Salt Lake City
The Salt Lake City, Utah, region is home to a growing medical device manufacturing sector. This Welcome address will help provide insights on exactly what the area has to offer and the impact the industry is having. Presented as a facts and figures overview, this session will kick off the 2026 MPO Summit.
9:00-9:45 a.m.
State of the Industry
The opening keynote of the 2026 MPO Summit will provide a focused look at many of the issues, challenges, and opportunities currently affecting the medical device manufacturing industry. Whether viewed by a representative of a supplier, contract manufacturer, OEM, or someone aligned with the industry in another way, this session is always well received and provides a wealth of information. M&A trends, emerging sectors, and other factors are covered as part of the presentation.
9:45-10:30 a.m.
The Growing Concern over PFAS: What's the Path Forward?
The medical device industry seeks materials that offer specific, beneficial characteristics depending on the application. Some of these substances, however, contain PFAS (per- and polyfluoroalkyl substances), also known as “forever chemicals.” These additives have garnered the attention of the EPA as well as organizations in the EU. As such, concerns have grown over their use and future availability. While medical devices may maintain access to them through an exemption, supply challenges could still be an issue. This session will discuss these materials, what the impact to device makers who use them could be, and what the future may hold for them.
11:15 a.m.-12:15 p.m.
Supplier Agreements in the Age of Partnerships
As OEM/supplier relationships continue to transform, what do current supplier agreements look like? What are today’s critical factors and what’s gone by the wayside? How do you develop a supplier agreement for a partnership rather than a transactional relationship? Representatives from both sides of the aisle—supplier and OEM—will share their experiences, best practices, and recommendations for navigating the intricacies of today’s agreements in this panel-based session.
Moderated by Paul Melnychuck
1:45-2:30 p.m.
Washington Update
With the midterm elections only a month away from the 2026 MPO Summit, gaining insights on where the government is headed will be invaluable. In addition to examining the congressional races and whether the House, Senate, or both will flip parties, this session will look at pressing concerns that impact medical device manufacturers. Aspects such as the CDRH’s focus and pending legislation will be highlighted and explained. Be informed on what can be expected from Washington.
2:30-3:15 p.m.
Session 6
Description to come
4:00-5:00 p.m.
Supply Chain Transformation: What's My Role?
As supplier consolidation continues and vertically integrated, full-service CDMOs continue to grow, questions emerge around supply chain resiliency and “boutique” suppliers. How will these organizations continue to exist in the new paradigm of medical device outsourcing? What role will they serve? Where do they fit into the outsourcing arrangement? Hear from representatives across the aisle from OEMs and service providers to gain insights on how the industry will look moving forward, where all parties fit, and best practices to leverage multiple players to ensure a resilient supply chain.
5:15-7:00 p.m.
9:00-10:00 a.m.
Developing the Devices for the Shrinking Size of Healthcare
Healthcare is getting smaller. That is, the technologies and devices being used to facilitate care, diagnosis, and treatment are shrinking in size. As a result, medical device manufacturers need to determine how best to accommodate this trend. Whether fabricating smaller parts, having less space in which to fit the necessary components, or adjusting production techniques to accommodate new outputs, miniaturization impacts almost everyone. With this in mind, panelists will discuss how this trend is affecting manufacturing and share best practices to help ensure accuracy and repeatability without significant increases in costs or time to market.
10:00-10:45 a.m
Session 9
Description to come
11:30 a.m.-12:30 p.m.
AI and Automation on the Production Floor
Most organizations recognize artificial intelligence (AI) can help improve processes and procedures, but still remain uncertain on how to implement it effectively. As a result, there are still reservations about incorporating it into a company’s manufacturing protocols. The panel for this session will attempt to alleviate common fears with using AI, eliminate misconceptions, and provide early steps for adoption. Targeting low-hanging fruit areas, the panel will offer best practices and important considerations that must be addressed before moving further into adoption.
12:30
End of Conference






